Skip to content
GLP-1 Scorecard
Menu
Graded #116

GoodRx

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

Visit GoodRxWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
$299/mo (brand Zepbound)
Coverage
All 50 states
Brand-name
Yes

Line GoodRx up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value80/100
Dose & formulation70/100
Clinical oversight69/100
Labs & monitoring51/100
Fulfillment81/100
Contract terms55/100

Strengths

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

Where it loses points

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves

Bottom line — Grade C

Best for: Shoppers who want self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies.

Ranked #116 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest GoodRx — the realistic shortlist.

The 18 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect GoodRx's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on GoodRx's site. Not medical advice; see our disclosure.

← Back to the scorecard